香港醫思醫療集團(02138.HK)預計中期盈利下降不多於75%
格隆匯 11 月 13日丨香港醫思醫療集團(02138.HK)公佈,集團截至2020年9月30日止的六個月的初步未經審計的銷售額(即已訂立的合約銷售以及集團提供的所有產品及服務所產生的銷售額的總和,簡稱"銷售額")預期錄得不少於9億港元,較去年同期下降不多於16%。
董事會基於目前可得的初步未經審計的集團管理帳目所作出最新評估,就2020年10月1日至2020年10月31日期間(簡稱"月內"),集團預期錄得:(i)月內銷售額不少於1.8億港元,較去年同期升幅不少於8%;及(ii)月內集團位於中國內地的診所以及服務中心之銷售額較去年同期升幅不少於35%。
董事會認為,集團的整體運作和財務狀況保持穩健。展望將來,集團對未來數個季度的業務均表現持樂觀態度。
集團截至2020年9月30日止的六個月(簡稱"期內")的税後淨溢利較2019年同期預期下降不多於75%。下降主要原因為期內香港政府為應對新型冠狀病毒疾病而公佈的一系列嚴格政策,包括但不限於(i)旅遊限制以及跨境旅客入境隔離;(ii)香港本地美容院強制關閉共72天;及(iii)社交距離限制措施,均引致消費者意欲減弱。
新型冠狀病毒疾病帶來全球性的空前影響,為營商環境帶來了巨大挑戰。儘管如此,集團一直以來採取積極態度應對挑戰,包括但不限於(i)持續通過有機增長以及併購模式發展新的醫療服務以及拓寬醫療領域範疇,以滿足客户主要的需求;(ii)積極與客户互動以留住本地忠實客户,及進行促銷活動以刺激本地客户消費;(iii)適時推出電子商務平台;及(iv)對租賃支出採取審慎財務管理及實行成本控制措施,以保存現金流及增強盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.